131 related articles for article (PubMed ID: 17595491)
1. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.
Azad R; Chandra P
Indian J Ophthalmol; 2007; 55(4):319; author reply 320. PubMed ID: 17595491
[No Abstract] [Full Text] [Related]
2. Off-label use of bevacizumab in retinopathy of prematurity.
Rishi E; Rishi P; Ratra D; Bhende M
Retina; 2009 Feb; 29(2):284; author reply 284-5. PubMed ID: 18854784
[No Abstract] [Full Text] [Related]
3. Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity.
Sangtam T; Vinekar A; Maheshwar B; Dogra MR; Eong KG
Indian J Ophthalmol; 2007; 55(4):317; author reply 317-8. PubMed ID: 17595489
[No Abstract] [Full Text] [Related]
4. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.
Travassos A; Teixeira S; Ferreira P; Regadas I; Travassos AS; Esperancinha FE; Prieto I; Pires G; van Velze R; Valido A; Machado Mdo C
Ophthalmic Surg Lasers Imaging; 2007; 38(3):233-7. PubMed ID: 17552391
[TBL] [Abstract][Full Text] [Related]
5. Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study.
Kong L; Mintz-Hittner HA; Penland RL; Kretzer FL; Chévez-Barrios P
Arch Ophthalmol; 2008 Aug; 126(8):1161-3. PubMed ID: 18695118
[No Abstract] [Full Text] [Related]
6. A new, theoretically safer method of intravitreal injection of bevacizumab in progressive retinopathy of prematurity using scleral trans-illumination.
Patel CK; Walker NJ; Kam JK
Br J Ophthalmol; 2010 Aug; 94(8):1107-9. PubMed ID: 20558426
[No Abstract] [Full Text] [Related]
7. Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity.
Law JC; Recchia FM; Morrison DG; Donahue SP; Estes RL
J AAPOS; 2010 Feb; 14(1):6-10. PubMed ID: 20227614
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
Hosseini H; Khalili MR; Nowroozizadeh S
Retina; 2009 Apr; 29(4):562. PubMed ID: 19262431
[No Abstract] [Full Text] [Related]
9. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
Nowroozzadeh MH
Retina; 2009 Apr; 29(4):564-5; author reply 565-8. PubMed ID: 19262428
[No Abstract] [Full Text] [Related]
10. Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment.
Hoang QV; Kiernan DF; Chau FY; Shapiro MJ; Blair MP
Arch Ophthalmol; 2010 Aug; 128(8):1080-1. PubMed ID: 20697016
[No Abstract] [Full Text] [Related]
11. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
Kychenthal A; Dorta P
Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
[TBL] [Abstract][Full Text] [Related]
12. Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity.
Shah PK; Morris RJ; Narendran V; Kalpana N
Indian J Ophthalmol; 2011; 59(1):73-4. PubMed ID: 21157086
[No Abstract] [Full Text] [Related]
13. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
Mintz-Hittner HA; Kuffel RR
Retina; 2008 Jun; 28(6):831-8. PubMed ID: 18536599
[TBL] [Abstract][Full Text] [Related]
14. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.
Chung EJ; Kim JH; Ahn HS; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1727-30. PubMed ID: 17690897
[TBL] [Abstract][Full Text] [Related]
15. Ultra-low dose of intravitreal bevacizumab in the treatment of retinopathy of prematurity.
Connor AJ; Papastavrou VT; Hillier RJ; Shafiq A
J Pediatr Ophthalmol Strabismus; 2015 Apr; 52 Online():e20-1. PubMed ID: 25942065
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.
Flavahan PW; Lavy TE; Wykes W
Scott Med J; 2013 Aug; 58(3):130-2. PubMed ID: 23960050
[TBL] [Abstract][Full Text] [Related]
17. What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?
Spandau U
Acta Ophthalmol; 2013 Mar; 91(2):e154. PubMed ID: 22989079
[No Abstract] [Full Text] [Related]
18. Bevacizumab for retinopathy of prematurity.
Lim LS; Mitchell P; Wong TY
N Engl J Med; 2011 Jun; 364(24):2360; author reply 2361-2. PubMed ID: 21675897
[No Abstract] [Full Text] [Related]
19. Prolonged follow-up period following intravitreal bevacizumab injection for stage 3+ retinopathy of prematurity.
de Klerk TA; Park DY; Biswas S
Eye (Lond); 2013 Oct; 27(10):1218. PubMed ID: 23846376
[No Abstract] [Full Text] [Related]
20. Bevacizumab for retinopathy of prematurity.
Gilbert CE; Zin A; Darlow B
N Engl J Med; 2011 Jun; 364(24):2359-60; author reply 2361-2. PubMed ID: 21675898
[No Abstract] [Full Text] [Related]
[Next] [New Search]